Jack Callicutt
Vermogen: 19 187 $ op 31-05-2026
Vermogen: 19 187 $ op 31-05-2026
Mr. Jack W.
Callicutt, CPA, is a Secretary, Chief Financial & Accounting Officer at Galectin Therapeutics, Inc. Mr. Callicutt was previously employed as a Chief Financial Officer by REACH Health, Inc., a Chief Financial Officer by Vystar Corp., a Chief Financial Officer & Vice President by Tikvah Therapeutics, Inc., a Senior Manager by Deloitte & Touche LLP, a Chief Financial Officer & Secretary by Corautus Genetics, Inc., and a Chief Financial Officer by IVOX, Inc. He received his undergraduate degree from Delta State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-01-2026 | 7.614 ( 0,01% ) | 19 187 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GALECTIN THERAPEUTICS INC. | Financieel Directeur/CFO | 01-07-2013 |
| Bedrijven | Functie | Einde |
|---|---|---|
REACH Health, Inc.
REACH Health, Inc. Packaged SoftwareTechnology Services Provides telemedicine software solutions for hospitals | Financieel Directeur/CFO | 01-06-2013 |
| VYSTAR CORPORATION | Financieel Directeur/CFO | 01-08-2012 |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Financieel Directeur/CFO | 01-03-2008 |
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Financieel Directeur/CFO | 07-06-2007 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 01-01-2003 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Corautus Genetics, Inc.
Corautus Genetics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy pharmaceutical products | Health Technology |
Galectin Therapeutics, Inc.
Galectin Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs to combat various diseases | Health Technology |
Vystar Corp.
Vystar Corp. Chemicals: SpecialtyProcess Industries Manufactures and distributes natural rubber latex | Process Industries |
Tikvah Therapeutics, Inc.
Tikvah Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops novel therapeutic products | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Delta State University
Delta State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
REACH Health, Inc.
REACH Health, Inc. Packaged SoftwareTechnology Services Provides telemedicine software solutions for hospitals | Technology Services |
IVOX, Inc.
IVOX, Inc. Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau